Drug General Information
Drug ID	D08FDI
Former ID	DNC005201
Drug Name	3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527190]
Structure		Download 2D MOL 3D MOL
Formula	C13H8N6
Canonical SMILES	C1=CC=NC(=C1)N2N=C(N=N2)C3=CC=CC(=C3)C#N
InChI	1S/C13H8N6/c14-9-10-4-3-5-11(8-10)13-16-18-19(17-13)12-6-1-2-7-15-12/h1-8H
InChIKey	GHRSDAGWCBAULR-UHFFFAOYSA-N
PubChem Compound ID	9813637
Target and Pathway
Target(s)	Metabotropic glutamate receptor 5	Target Info	Inhibitor	[527190]
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Gap junction
	Long-term potentiation
	Retrograde endocannabinoid signaling
	Glutamatergic synapse
	Huntington's disease
PANTHER Pathway	Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
	Metabotropic glutamate receptor group III pathway
	Metabotropic glutamate receptor group I pathway
	Endogenous cannabinoid signaling
Reactome	G alpha (q) signalling events
	Class C/3 (Metabotropic glutamate/pheromone receptors)
WikiPathways	Hypothetical Network for Drug Addiction
	GPCRs, Class C Metabotropic glutamate, pheromone
	Gastrin-CREB signalling pathway via PKC and MAPK
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 527190	J Med Chem. 2004 Sep 9;47(19):4645-8.Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.
Ref 527190	J Med Chem. 2004 Sep 9;47(19):4645-8.Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.